Compare SNY & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNY | MCK |
|---|---|---|
| Founded | 1994 | 1833 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 107.4B |
| IPO Year | N/A | N/A |
| Metric | SNY | MCK |
|---|---|---|
| Price | $49.34 | $808.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $61.50 | ★ $876.25 |
| AVG Volume (30 Days) | ★ 2.3M | 797.6K |
| Earning Date | 10-24-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.23% | 0.41% |
| EPS Growth | ★ 105.93 | 66.19 |
| EPS | 8.67 | ★ 32.12 |
| Revenue | $53,890,648,839.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $2.37 | $14.87 |
| Revenue Next Year | $6.51 | $8.32 |
| P/E Ratio | ★ $11.25 | $25.18 |
| Revenue Growth | N/A | ★ 17.23 |
| 52 Week Low | $44.62 | $558.13 |
| 52 Week High | $60.12 | $895.58 |
| Indicator | SNY | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 40.44 |
| Support Level | $48.89 | $802.72 |
| Resistance Level | $50.43 | $895.58 |
| Average True Range (ATR) | 0.73 | 18.05 |
| MACD | -0.15 | -10.25 |
| Stochastic Oscillator | 19.29 | 4.61 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.